YCD-19853-83112
3 vaccinations
11 coded responses
33 check-ins
10 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 31-35
- ZIP prefix
- 206 / MD
- Registered
- 2021-06-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-18
Registered in v-safe
-
2021-06-18
Dose 1 — Pfizer-BioNTech
-
2021-06-18
Survey response — day 0, dose 1MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-19
-
2021-06-20
Survey response — days 1–6 daily, dose 1MedDRA: Erythema — Feeling: GoodFree text: Experiencing redness in left eye that is much heavier than normal.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-21
Survey response — days 1–6 daily, dose 1MedDRA: Asthenopia, Eye haemorrhage, Ocular hyperaemia — Feeling: Good · Be unable to work or attend schoolFree text: Heavy reddening of the left eye. Looks like a broken blood vessel in the eyeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-22
Survey response — days 1–6 daily, dose 1MedDRA: Ocular hyperaemia — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Redness of the left eyeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-22
Report sent to call center — days 1–6 daily, dose 1Be unable to work or attend school · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-06-23
Survey response — days 1–6 daily, dose 1MedDRA: Ocular hyperaemia — Feeling: GoodFree text: Left eye redness still present but now finally beginning to lessen.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-24
Survey response — days 1–6 daily, dose 1MedDRA: Ocular hyperaemia — Feeling: GoodFree text: Still have redness in left eye, but is now steadily decreasingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-25
Survey response — day 7, dose 1MedDRA: Ocular hyperaemia — Feeling: GoodFree text: Redness in left eye continuing to dissipate. But still monitoring.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-29
-
2021-06-29
Call successfulCompleted over the phone
- 2021-07-02
-
2021-07-09
Dose 2 — Pfizer-BioNTech
- 2021-07-16
- 2021-07-23
- 2021-07-30
- 2021-08-06
- 2021-08-13
- 2021-08-20
- 2021-10-08
-
2022-01-07
Dose 3 — Pfizer-BioNTech
- 2022-01-07
- 2022-01-07
-
2022-01-08
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Joint pains, Muscle or body achesAdult check-in
- 2022-01-09
- 2022-01-10
- 2022-01-11
-
2022-01-12
Survey response — days 1–6 daily, dose 3MedDRA: Cough, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Congestion/Runny Nose and CoughingMedDRA releases: 2024-11 · check-in free text available
-
2022-01-13
Survey response — days 1–6 daily, dose 3MedDRA: COVID-19 — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Have been diagnosed with COVID-19 despite being vaccinated.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-14
Survey response — day 7, dose 3MedDRA: COVID-19, Cough, Respiratory tract congestion — Feeling: Fair · Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Have been diagnosed with COVID-19 as of 1/13/22. Have had coughing, congestionMedDRA releases: 2024-11 · check-in free text available
- 2022-01-21
- 2022-01-28
- 2022-02-04
- 2022-02-11
- 2022-02-18
- 2022-04-08
- 2022-07-08
-
2023-01-07
Survey response — 12 months, dose 3MedDRA: Inflammation, Ocular hyperaemia — Feeling: GoodMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-18 | Pfizer-BioNTech | |
| 2 | 2021-07-09 | Pfizer-BioNTech | No |
| 3 | 2022-01-07 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-06-22 | Successful 2021-06-29 |
Completed over the phone |
Free text
Release 9 — day 0, dose 1
Systemic reaction (other): No
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Experiencing redness in left eye that is much heavier than normal.
Systemic reaction (other): Heavy reddening of the left eye. Looks like a broken blood vessel in the eye
Systemic reaction (other): Redness of the left eye
Systemic reaction (other): Left eye redness still present but now finally beginning to lessen.
Systemic reaction (other): Still have redness in left eye, but is now steadily decreasing
Release 9 — day 7, dose 1
Systemic reaction (other): Redness in left eye continuing to dissipate. But still monitoring.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Congestion/Runny Nose and Coughing
Systemic reaction (other): Have been diagnosed with COVID-19 despite being vaccinated.
Release 10 — day 7, dose 3
Systemic reaction (other): Have been diagnosed with COVID-19 as of 1/13/22. Have had coughing, congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Inflammation | · | · | ✓ |
| SD | Ocular hyperaemia | · | · | ✓ |
| SRO | Asthenopia | ✓ | ✓ | ✓ |
| SRO | Cough | · | · | ✓ |
| SRO | COVID-19 | · | · | ✓ |
| SRO | Erythema | ✓ | ✓ | ✓ |
| SRO | Eye haemorrhage | ✓ | ✓ | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
| SRO | Ocular hyperaemia | ✓ | ✓ | ✓ |
| SRO | Respiratory tract congestion | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release